Niacin improves renal lipid metabolism and slows progression in chronic kidney disease |
| |
Authors: | Kyu-hyang Cho Hyun-ju Kim Vaijinath S Kamanna Nosratola D Vaziri |
| |
Institution: | 1. Division of Nephrology and Hypertension, University of California, Irvine, Irvine, CA, USA;2. Department of Internal Medicine, Yeungnam University, Daegu, Korea;3. Atherosclerosis Research Center, Department of Veterans Affairs Healthcare System, Long Beach, CA, USA |
| |
Abstract: | BackgroundMounting evidence points to lipid accumulation in the diseased kidney and its contribution to progression of nephropathy. We recently found heavy lipid accumulation and marked dysregulation of lipid metabolism in the remnant kidneys of rats with chronic renal failure (CRF). Present study sought to determine efficacy of niacin supplementation on renal tissue lipid metabolism in CRF.MethodsKidney function, lipid content, and expression of molecules involved in cholesterol and fatty acid metabolism were determined in untreated CRF (5/6 nephrectomized), niacin-treated CRF (50 mg/kg/day in drinking water for 12 weeks) and control rats.ResultsCRF resulted in hypertension, proteinuria, renal tissue lipid accumulation, up-regulation of scavenger receptor A1 (SR-A1), acyl-CoA cholesterol acyltransferase-1 (ACAT1), carbohydrate-responsive element binding protein (ChREBP), fatty acid synthase (FAS), acyl-CoA carboxylase (ACC), liver X receptor (LXR), ATP binding cassette (ABC) A-1, ABCG-1, and SR-B1 and down-regulation of sterol responsive element binding protein-1 (SREBP-1), SREBP-2, HMG-CoA reductase, PPAR-α, fatty acid binding protein (L-FABP), and CPT1A. Niacin therapy attenuated hypertension, proteinuria, and tubulo-interstitial injury, reduced renal tissue lipids, CD36, ChREBP, LXR, ABCA-1, ABCG-1, and SR-B1 abundance and raised PPAR-α and L-FABP.Conclusions and general significanceNiacin administration improves renal tissue lipid metabolism and renal function and structure in experimental CRF. |
| |
Keywords: | Inflammation Proteinuria Hypertension Atherosclerosis Reverse cholesterol transport Oxidative stress Anti-inflammatory-antioxidant agent |
本文献已被 ScienceDirect 等数据库收录! |
|